Beneficial effects of concomitant neuronal and inducible nitric oxide synthase inhibition in ovine burn and inhalation injury

Shock

Volumn 35, Issue 6, 2011, Pages 626-631

  Lange, Matthias ^a,b   Hamahata, Atsumori ^a   Enkhbaatar, Perenlei ^a   Cox, Robert A ^a   Nakano, Yoshimitsu ^a   Westphal, Martin ^a,b   Traber, Lillian D ^a   Herndon, David N ^a   Traber, Daniel L ^a  

^a SHRINERS HOSPITALS FOR CHILDREN   (United States)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Acute lung injury; microvascular hyperpermeability; nitric oxide; sheep

Indexed keywords

7 NITROINDAZOLE; INDUCIBLE NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE; NITRATE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; UNCLASSIFIED DRUG; ZK 809984;

ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL VENTILATION; BLOOD OXYGEN TENSION; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FLUID RESUSCITATION; LUNG BURN; LUNG LESION; LUNG LYMPH FLOW; NONHUMAN; PULMONARY SHUNT;

ACUTE LUNG INJURY; ANIMALS; BURNS; CAPILLARY PERMEABILITY; FEMALE; HEART RATE; IMIDAZOLES; INDAZOLES; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE II; NITROGEN OXIDES; PIPERAZINES; PULMONARY GAS EXCHANGE; PYRIMIDINES; RESPIRATORY DISTRESS SYNDROME, ADULT; SHEEP, DOMESTIC; SMOKE INHALATION INJURY;

EID: 79957913557     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0b013e31820fe671     Document Type: Article

References (29)

1. Palmieri TL, Warner P, Mlcak RP, Sheridan R, Kagan RJ, Herndon DN, Tompkins R, Greenhalgh DG: Inhalation injury in children: a 10 year experience at Shriners Hospitals for Children. J Burn Care Res 30(1):206-208, 2009.
2. Shirani KZ, Pruitt BA Jr, Mason AD Jr: The influence of inhalation injury and pneumonia on burn mortality. Ann Surg 205(1):82-87, 1987. (Pubitemid 17225029)
3. Murakami K, Traber DL: Pathophysiological basis of smoke inhalation injury. News Physiol Sci 18:125-129, 2003. (Pubitemid 36782803)
4. Soejima K, Schmalstieg FC, Sakurai H, Traber LD, Traber DL: Pathophysio-logical analysis of combined burn and smoke inhalation injuries in sheep. Am J Physiol Lung Cell Mol Physiol 280(6):L1233-L1241, 2001.
5. Cox RA, Burke AS, Soejima K, Murakami K, Katahira J, Traber LD, Herndon DN, Schmalstieg FC, Traber DL, Hawkins HK: Airway obstruction in sheep with burn and smoke inhalation injuries. Am J Respir Cell Mol Biol 29(3):295-302, 2003. (Pubitemid 37093987)
6. Enkhbaatar P, Murakami K, Shimoda K, Mizutani A, Traber L, Phillips GB, Parkinson JF, Cox R, Hawkins H, Herndon D, et al.: The inducible nitric oxide synthase inhibitor BBS-2 prevents acute lung injury in sheep after burn and smoke inhalation injury. Am J Respir Crit Care Med 167(7):1021-1026, 2003. (Pubitemid 36408169)
7. Cox RA, Jacob S, Oliveras G, Murakami K, Enkhbaatar P, Traber L, Schmalstieg FC, Herndon DN, Traber DL, Hawkins HK: Pulmonary expression of nitric oxide synthase isoforms in sheep with smoke inhalation and burn injury. Exp Lung Res 35(2):104-118, 2009.
8. Enkhbaatar P, Murakami K, Shimoda K, Mizutani A, Traber L, Phillips G, Parkinson J, Salsbury JR, Biondo N, Schmalstieg F, et al.: Inducible nitric oxide synthase dimerization inhibitor prevents cardiovascular and renal morbidity in sheep with combined burn and smoke inhalation injury. Am J Physiol Heart Circ Physiol 285(6):H2430-H2436, 2003.
9. Soejima K, McGuire R, Snyder NT, Uchida T, Szabo C, Salzman A, Traber LD, Traber DL: The effect of inducible nitric oxide synthase (iNOS) inhibition on smoke inhalation injury in sheep. Shock 13(4):261-266, 2000.
10. Soejima K, Traber LD, Schmalstieg FC, Hawkins H, Jodoin JM, Szabo C, Szabo E, Virag L, Salzman A, Traber DL: Role of nitric oxide in vascular permeability after combined burns and smoke inhalation injury. Am J Respir Crit Care Med 163(3 Pt 1):745-752, 2001. (Pubitemid 32230839)
11. Saunders FD, Westphal M, Enkhbaatar P, Wang J, Pazdrak K, Nakano Y, Hamahata A, Jonkam CC, Lange M, Connelly RL, et al.: Molecular biological effects of selective neuronal nitric oxide synthase inhibition in ovine lung injury. Am J Physiol Lung Cell Mol Physiol 298(3):L427-L436, 2010.
12. Westphal M, Enkhbaatar P, Schmalstieg FC, Kulp GA, Traber LD, Morita N, Cox RA, Hawkins HK, Westphal-Varghese BB, Rudloff HE, et al.: Neuronal nitric oxide synthase inhibition attenuates cardiopulmonary dysfunctions after combined burn and smoke inhalation injury in sheep. Crit Care Med 36(4): 1196-1204, 2008. (Pubitemid 351482669)
13. Lange M, Enkhbaatar P, Traber DL, Cox RA, Jacob S, Mathew BP, Hamahata A, Traber LD, Herndon DN, Hawkins HK: Role of calcitonin gene-related peptide (CGRP) in ovine burn and smoke inhalation injury. J Appl Physiol 107(1):176-184, 2009.
14. Blasko E, Glaser CB, Devlin JJ, Xia W, Feldman RI, Polokoff MA, Phillips GB, Whitlow M, Auld DS, McMillan K, et al.: Mechanistic studies with potent and selective inducible nitric-oxide synthase dimerization inhibitors. J Biol Chem 277(1): 295-302, 2002. (Pubitemid 34952058)
15. Enkhbaatar P, Murakami K, Shimoda K, Mizutani A, McGuire R, Schmalstieg F, Cox R, Hawkins H, Jodoin J, Lee S, et al.: Inhibition of neuronal nitric oxide synthase by 7-nitroindazole attenuates acute lung injury in an ovine model. Am J Physiol Regul Integr Comp Physiol 285(2):R366-R372, 2003. (Pubitemid 36898906)
16. Enkhbaatar P, Murakami K, Traber LD, Cox R, Parkinson JF, Westphal M, Esechie A, Morita N, Maybauer MO, Maybauer DM, et al.: The inhibition of inducible nitric oxide synthase in ovine sepsis model. Shock 25(5):522-527, 2006.
17. Lange M, Connelly R, Traber DL, Hamahata A, Cox RA, Nakano Y, Bansal K, Esechie A, von Borzyskowski S, Jonkam C, et al.: Combined neuronal and inducible nitric oxide synthase inhibition in ovine acute lung injury. Crit Care Med 37(1):223-229, 2009.
18. Vidal Melo MF, Harris RS, Layfield D, Musch G, Venegas JG: Changes in regional ventilation after autologous blood clot pulmonary embolism. Anesthe-siology 97(3):671-681, 2002. (Pubitemid 34977328)
19. Hinder F, Meyer J, Booke M, Ehardt JS, Salsbury JR, Traber LD, Traber DL: Endogenous nitric oxide and the pulmonary microvasculature in healthy sheep and during systemic inflammation. Am J Respir Crit Care Med 157(5 Pt 1): 1542-1549, 1998.
20. Pearce ML, Yamashita J, Beazell J: Measurement of pulmonary edema. Circ Res 16:482-488, 1965.
21. Nathan C, Xie QW: Nitric oxide synthases: roles, tolls, and controls. Cell 78(6): 915-918, 1994. (Pubitemid 24292319)
22. Titheradge MA: Nitric oxide in septic shock. Biochim Biophys Acta 1411(2-3): 437-455, 1999. (Pubitemid 29221966)
23. Gocan NC, Scott JA, Tyml K: Nitric oxide produced via neuronal NOS may impair vasodilatation in septic rat skeletal muscle. Am J Physiol Heart Circ Physiol 278(5):H1480-H1489, 2000. (Pubitemid 30395558)
24. McKinnon RL, Lidington D, Bolon M, Ouellette Y, Kidder GM, Tyml K: Reduced arteriolar conducted vasoconstriction in septic mouse cremaster muscle is mediated by nNOS-derived NO. Cardiovasc Res 69(1):236-244, 2006. (Pubitemid 41814825)
25. Moncada S, Higgs A: The L-arginineYnitric oxide pathway. N Engl J Med 329(27):2002-2012, 1993.
26. Carvalho P, Thompson WH, Charan NB: Comparative effects of alpha-receptor stimulation and nitrergic inhibition on bronchovascular tone. J Appl Physiol 88(5):1685-1689, 2000. (Pubitemid 30336919)
27. Westphal M, Cox RA, Traber LD, Morita N, Enkhbaatar P, Schmalstieg FC, Hawkins HK, Maybauer DM, Maybauer MO, Murakami K, et al.: Combined burn and smoke inhalation injury impairs ovine hypoxic pulmonary vaso-constriction. Crit Care Med 34(5):1428-1436, 2006.
28. Lopez A, Lorente JA, Steingrub J, Bakker J, McLuckie A, Willatts S, Brockway M, Anzueto A, Holzapfel L, Breen D, et al.: Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 32(1):21-30, 2004. (Pubitemid 38125559)
29. Bakker J, Grover R, McLuckie A, Holzapfel L, Andersson J, Lodato R, Watson D, Grossman S, Donaldson J, Takala J: Administration of the nitric oxide synthase inhibitor NG-methylYL-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002). Crit Care Med 32(1):1-12, 2004. (Pubitemid 38125557)